New York and Jerusalem, 23 June, 2011 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, and Ex Libris® Group, a global leader in the provision of library automation solutions, today announced their collaboration to make the full text of SciVerse ScienceDirect journal articles and ebooks searchable in the Ex Libris Primo Central Index.
Primo Central is an integral part of the Ex Libris Primo® discovery and delivery solution, which enables library users to enjoy the full benefit of a one-stop service for their information needs. Primo enables users to explore their library's locally managed collections along with global and regional resources indexed in Primo Central.
Offered as a cloud-based service to hundreds of libraries around the globe, the world-class Primo Central Index covers hundreds of millions of scholarly resources from leading information providers. It now includes full-text journal articles and books chapters from SciVerse ScienceDirect. Part of the SciVerse suite of search and discovery products offered by Elsevier, SciVerse ScienceDirect consists of more than 2,000 peer-reviewed journals and 20,000 books and major reference works, more than 10.5 million articles and chapters with nearly 500,000 added every year.
"By providing our library users with the extensive scope of scientific, technical and medical peer-reviewed content from SciVerse ScienceDirect, we are closer to our goal of providing a definitive research experience," said Oren Beit-Arie, Ex Libris' Chief Strategy Officer. "In a recent pilot program with selected leading institutions around the world Primo was shown to have a considerable impact on the discoverability of SciVerse ScienceDirect content."
"Recognizing the ever growing need for researchers to find information quickly, we feel it is important to further expand the discoverability of content from SciVerse ScienceDirect through solutions such as Ex Libris," said Yukun Harsono, Senior Vice President, Search & Discovery, Academic and Government Markets at Elsevier. "Ex Libris' commitment to creating efficient, user-friendly products aligns with our mission to advance scientific search and discovery for all of our users. We look forward to further collaboration in order to address the needs of librarians and researchers alike."
About Ex Libris
Ex Libris is a leading provider of automation solutions for academic libraries. Offering the only comprehensive product suite for electronic, digital, and print materials, Ex Libris provides efficient, user-friendly products that serve the needs of libraries today and will facilitate their transition into the future. Ex Libris maintains an impressive customer base consisting of thousands of sites in more than 80 countries on six continents.
Dedicated to developing creative solutions in close collaboration with customers, Ex Libris enables academic, national, and research libraries to maximize productivity and efficiency and, at the same time, greatly enhance the user experience. By empowering users to discover and obtain the information they need, libraries ensure their position as the bridge to knowledge.
For more information about Ex Libris Group, see our Web site (www.exlibrisgroup.com), join us on Facebook, visit our Commentary blog, and follow our Twitter page.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).